AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.34
−0.19%Margins
Gross margin
67.0%
EBITDA margin
-113.3%
EBIT margin
-97.5%
Net margin
-144.6%
FCF margin
-85.0%
138.2%
Return on equity
-59.2%
Return on assets
-2185.9%
Return on invested capital
0.40x
Asset turnover
-$45.4M
Cash from operations
$0.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026